PatientsVille.com Logo

Ixempra Side Effects

PatientsVille

Common Ixempra Side Effects


The most commonly reported Ixempra side effects (click to view or check a box to report):

Malignant Neoplasm Progression (53)
Fatigue (45)
Death (44)
Diarrhoea (43)
Neutropenia (38)
Neuropathy Peripheral (38)
Nausea (37)
Febrile Neutropenia (37)
Vomiting (36)
Dehydration (32)
Dyspnoea (28)
Pyrexia (21)
Stomatitis (21)
Sepsis (21)
Pancytopenia (20)
Asthenia (17)
Mucosal Inflammation (17)
Hypotension (17)
Hypersensitivity (16)
No Adverse Event (16)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Ixempra Side Effects Reported to FDA



Ixempra Side Effect Report#9993626
Malignant Neoplasm Progression
This is a report of a 51-year-old female patient (weight: NA) from IN, suffering from the following health symptoms/conditions: breast cancer, who was treated with Ixempra (dosage: NA, start time:
Aug 06, 2013), combined with: NA. and developed a serious reaction and side effect(s): Malignant Neoplasm Progression after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ixempra treatment in female patients, resulting in Malignant Neoplasm Progression side effect.
Ixempra Side Effect Report#9992799
Malignant Neoplasm Progression
This report suggests a potential Ixempra Malignant Neoplasm Progression side effect(s) that can have serious consequences. A 35-year-old female patient (weight: NA) from IN was diagnosed with the following symptoms/conditions: breast cancer and used Ixempra (dosage: NA) starting
Mar 16, 2013. After starting Ixempra the patient began experiencing various side effects, including: Malignant Neoplasm ProgressionAdditional drugs used concurrently: NA. Although Ixempra demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Malignant Neoplasm Progression, may still occur.
Ixempra Side Effect Report#9981442
Respiratory Arrest
This Respiratory Arrest problem was reported by a health professional from CO. A 35-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Dec 30, 2013 this consumer started treatment with Ixempra (dosage: Int 27feb14). The following drugs were being taken at the same time: NA. When using Ixempra, the patient experienced the following unwanted symptoms/side effects: Respiratory ArrestAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Respiratory Arrest, may become evident only after a product is in use by the general population.
Ixempra Side Effect Report#9914608
Syncope, Hyponatraemia, Hypotension, Electrocardiogram Qt Prolonged, Lymphocyte Count Decreased, Febrile Neutropenia, Hypokalaemia, Alanine Aminotransferase Increased, Hypophosphataemia
This Syncope side effect was reported by a consumer or non-health professional from US. A 67-year-old female patient (weight:NA) experienced the following symptoms/conditions: neoplasm malignant.The patient was prescribed Ixempra (drug dosage: Recent Dose 13jan14?32mg/m2 Iv Over 3 Hours On Day 1), which was initiated on
Jan 13, 2014. Concurrently used drugs:
  • Temsirolimus (Recent Dose 13jan14?15mg Iv Over 30-60mins On Day 1 + 8)
.After starting to take Ixempra the consumer reported adverse symptoms, such as: Syncope, Hyponatraemia, Hypotension, Electrocardiogram Qt Prolonged, Lymphocyte Count Decreased, Febrile Neutropenia, Hypokalaemia, Alanine Aminotransferase Increased, HypophosphataemiaThese side effects may potentially be related to Ixempra. The patient was hospitalized.
Ixempra Side Effect Report#9897413
Neutropenia, Rash, Asthenia
This is a report of a 51-year-old female patient (weight: NA) from ZA, suffering from the following health symptoms/conditions: breast cancer, who was treated with Ixempra (dosage: NA, start time:
Jan 16, 2014), combined with: NA. and developed a serious reaction and side effect(s): Neutropenia, Rash, Asthenia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ixempra treatment in female patients, resulting in Neutropenia side effect. The patient was hospitalized.
Ixempra Side Effect Report#9870203
Pleural Effusion
This report suggests a potential Ixempra Pleural Effusion side effect(s) that can have serious consequences. A 59-year-old female patient (weight: NA) from CO was diagnosed with the following symptoms/conditions: breast cancer metastatic and used Ixempra (dosage: NA) starting
Aug 05, 2013. After starting Ixempra the patient began experiencing various side effects, including: Pleural EffusionAdditional drugs used concurrently: NA.The patient was hospitalized. Although Ixempra demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pleural Effusion, may still occur.
Ixempra Side Effect Report#9861871
This Death problem was reported by a consumer or non-health professional from AR. A 35-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: breast cancer. On 201312 this consumer started treatment with Ixempra (dosage: NA). The following drugs were being taken at the same time: NA. When using Ixempra, the patient experienced the following unwanted symptoms/side effects:Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Death, may become evident only after a product is in use by the general population.
Ixempra Side Effect Report#9842373
Cardio-respiratory Arrest, Abdominal Pain, Myalgia, Headache, Gallbladder Pain, Oropharyngeal Pain
This Cardio-respiratory Arrest side effect was reported by a consumer or non-health professional from CO. A 44-year-old female patient (weight:NA) experienced the following symptoms/conditions: breast cancer metastatic.The patient was prescribed Ixempra (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Ixempra the consumer reported adverse symptoms, such as: Cardio-respiratory Arrest, Abdominal Pain, Myalgia, Headache, Gallbladder Pain, Oropharyngeal PainThese side effects may potentially be related to Ixempra.
Ixempra Side Effect Report#9839360
Malignant Neoplasm Progression
This is a report of a 43-year-old female patient (weight: NA) from IN, suffering from the following health symptoms/conditions: breast cancer, who was treated with Ixempra (dosage: Last Dose 29apr13, start time:
Apr 15, 2013), combined with: NA. and developed a serious reaction and side effect(s): Malignant Neoplasm Progression after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ixempra treatment in female patients, resulting in Malignant Neoplasm Progression side effect.
Ixempra Side Effect Report#9836590
Pneumonia Viral, Pyrexia, Neutropenia, Productive Cough
This report suggests a potential Ixempra Pneumonia Viral side effect(s) that can have serious consequences. A 46-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: breast cancer and used Ixempra (dosage: NA) starting
Dec 31, 2013. After starting Ixempra the patient began experiencing various side effects, including: Pneumonia Viral, Pyrexia, Neutropenia, Productive CoughAdditional drugs used concurrently:
  • Erbitux (cetuximab)
  • Vicodin
  • Clindamycin
  • Doxycycline
The patient was hospitalized. Although Ixempra demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pneumonia Viral, may still occur.
Ixempra Side Effect Report#9832947
Yellow Skin
This Death problem was reported by a consumer or non-health professional from CO. A 57-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Dec 09, 2013 this consumer started treatment with Ixempra (dosage: NA). The following drugs were being taken at the same time: NA. When using Ixempra, the patient experienced the following unwanted symptoms/side effects: Yellow SkinThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Death, may become evident only after a product is in use by the general population.
Ixempra Side Effect Report#9832655
Malignant Neoplasm Progression, Pleural Effusion, Dyspnoea, Inflammation
This Malignant Neoplasm Progression side effect was reported by a consumer or non-health professional from CO. A 44-year-old female patient (weight:NA) experienced the following symptoms/conditions: breast cancer metastatic.The patient was prescribed Ixempra For Inj (drug dosage: NA), which was initiated on
Nov 27, 2013. Concurrently used drugs: NA..After starting to take Ixempra For Inj the consumer reported adverse symptoms, such as: Malignant Neoplasm Progression, Pleural Effusion, Dyspnoea, InflammationThese side effects may potentially be related to Ixempra For Inj. The patient was hospitalized.
Ixempra Side Effect Report#9764505
Platelet Count Decreased, Cystitis, Dehydration, Pyrexia, Muscular Weakness, Neutrophil Count Decreased, White Blood Cell Count Decreased, Anaemia
This is a report of a 66-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: endometrial adenocarcinoma, who was treated with Ixempra (dosage: Interrupted On 21jun11: 7days. 30 Mg/m2 Iv Over 1 Hr On Day I X 6 Cycles, start time:
Mar 29, 2011), combined with:
  • Carboplatin (Inter On 21jun2011: 7days. Auc = 6 Iv Over 30 Minutes On Day 1 X 6 Cycles.)
  • Rhumab-e25 (Interrupted On 21jun11: 7days. 15 Mg/kg Iv Over 3 0-90 Minutes On Day 1 X 6 Cycles)
and developed a serious reaction and side effect(s): Platelet Count Decreased, Cystitis, Dehydration, Pyrexia, Muscular Weakness, Neutrophil Count Decreased, White Blood Cell Count Decreased, Anaemia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ixempra treatment in female patients, resulting in Platelet Count Decreased side effect. The patient was hospitalized.
Ixempra Side Effect Report#9739425
Haematemesis, Diarrhoea
This report suggests a potential Ixempra Haematemesis side effect(s) that can have serious consequences. A 60-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: breast cancer and used Ixempra (dosage: NA) starting 2013. After starting Ixempra the patient began experiencing various side effects, including: Haematemesis, DiarrhoeaAdditional drugs used concurrently:
  • Herceptin
The patient was hospitalized. Although Ixempra demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Haematemesis, may still occur.
Ixempra Side Effect Report#9739420
Malignant Neoplasm Progression
This Malignant Neoplasm Progression problem was reported by a health professional from US. A 45-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Ixempra (dosage: Last Dose Was 20may2013). The following drugs were being taken at the same time: NA. When using Ixempra, the patient experienced the following unwanted symptoms/side effects: Malignant Neoplasm ProgressionAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Malignant Neoplasm Progression, may become evident only after a product is in use by the general population.
Ixempra Side Effect Report#9739407
Somnolence, Neuropathy Peripheral
This Somnolence side effect was reported by a health professional from US. A 78-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Ixempra For Inj (drug dosage: No. Of. Infusions: 3?discontinued And Reason Was Not Provided), which was initiated on
Dec 01, 2012. Concurrently used drugs:
  • Benadryl
.After starting to take Ixempra For Inj the consumer reported adverse symptoms, such as: Somnolence, Neuropathy PeripheralThese side effects may potentially be related to Ixempra For Inj.
Ixempra Side Effect Report#9739405
Neuropathy Peripheral
This is a report of a 57-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: breast cancer metastatic, who was treated with Ixempra (dosage: Interrupted On 27jul2012;?restarted On 01nov2012 With 32mg/m2, start time:
Feb 16, 2012), combined with: NA. and developed a serious reaction and side effect(s): Neuropathy Peripheral after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ixempra treatment in female patients, resulting in Neuropathy Peripheral side effect.
Ixempra Side Effect Report#9739404
Myalgia
This report suggests a potential Ixempra Myalgia side effect(s) that can have serious consequences. A 66-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Ixempra (dosage: Received Two Infusions) starting NS. After starting Ixempra the patient began experiencing various side effects, including: MyalgiaAdditional drugs used concurrently: NA. Although Ixempra demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Myalgia, may still occur.
Ixempra Side Effect Report#9739403
Palmar-plantar Erythrodysaesthesia Syndrome, Feeling Abnormal
This Palmar-plantar Erythrodysaesthesia Syndrome problem was reported by a health professional from US. A 56-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: breast cancer metastatic. On
Nov 27, 2012 this consumer started treatment with Ixempra (dosage: Postponed Due To Event). The following drugs were being taken at the same time:
  • Xeloda
  • Oxycontin
  • Zyrtec
  • Diovan Hct (1df=160/12.5)
  • Lexapro
  • Ambien (At Bedtime)
  • Ativan
  • Compazine
When using Ixempra, the patient experienced the following unwanted symptoms/side effects: Palmar-plantar Erythrodysaesthesia Syndrome, Feeling AbnormalAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Palmar-plantar Erythrodysaesthesia Syndrome, may become evident only after a product is in use by the general population.
Ixempra Side Effect Report#9739402
Muscle Spasms, Fatigue
This Muscle Spasms side effect was reported by a consumer or non-health professional from US. A 66-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Ixempra (drug dosage: 2 Treatments), which was initiated on NS. Concurrently used drugs:
  • Venlafaxine Hcl
  • Gabapentin
  • Omeprazole
  • Vitamin B
.After starting to take Ixempra the consumer reported adverse symptoms, such as: Muscle Spasms, FatigueThese side effects may potentially be related to Ixempra.
Ixempra Side Effect Report#9739401
Chest Pain
This is a report of a 65-year-old patient (weight: NA) from US, suffering from the following health symptoms/conditions: NA, who was treated with Ixempra (dosage: NA, start time: 201301), combined with: NA. and developed a serious reaction and side effect(s): Chest Pain after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ixempra treatment in patients, resulting in Chest Pain side effect.
Ixempra Side Effect Report#9739393
Pancytopenia
This report suggests a potential Ixempra Pancytopenia side effect(s) that can have serious consequences. A 63-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Ixempra (dosage: No Of Doses:2) starting NS. After starting Ixempra the patient began experiencing various side effects, including: PancytopeniaAdditional drugs used concurrently: NA. Although Ixempra demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pancytopenia, may still occur.
Ixempra Side Effect Report#9739390
Wound, Constipation, Nausea, Decreased Appetite, Dysgeusia, Breast Atrophy, Dry Mouth, Weight Increased, Breast Hyperplasia
This Wound problem was reported by a consumer or non-health professional from US. A 57-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: breast cancer. On 201208 this consumer started treatment with Ixempra (dosage: NA). The following drugs were being taken at the same time:
  • Neulasta
  • Zyprexa
  • Tamoxifen
  • Iron
When using Ixempra, the patient experienced the following unwanted symptoms/side effects: Wound, Constipation, Nausea, Decreased Appetite, Dysgeusia, Breast Atrophy, Dry Mouth, Weight Increased, Breast HyperplasiaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Wound, may become evident only after a product is in use by the general population.
Ixempra Side Effect Report#9734566
Presyncope, Anaemia, Constipation, Hypokalaemia
This Presyncope side effect was reported by a consumer or non-health professional from US. A 63-year-old female patient (weight:NA) experienced the following symptoms/conditions: endometrial cancer.The patient was prescribed Ixempra (drug dosage: 30mg/m2 Over 1 Hr On Day 1 X 6 Cycles?courses:5), which was initiated on
Dec 07, 2010. Concurrently used drugs:
  • Carboplatin (Auc:6 Over 30 Min On Day 1 X 6cycles?courses:5)
  • Bevacizumab (15mg/kg Over 30-90min On Day 1?courses:5)
.After starting to take Ixempra the consumer reported adverse symptoms, such as: Presyncope, Anaemia, Constipation, HypokalaemiaThese side effects may potentially be related to Ixempra. The patient was hospitalized.
Ixempra Side Effect Report#9618030
Capillary Leak Syndrome
This is a report of a 52-year-old female patient (weight: NA) from IL, suffering from the following health symptoms/conditions: breast cancer metastatic, who was treated with Ixempra (dosage: Int 25jul13, start time:
Jul 25, 2013), combined with: NA. and developed a serious reaction and side effect(s): Capillary Leak Syndrome after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ixempra treatment in female patients, resulting in Capillary Leak Syndrome side effect. The patient was hospitalized.


1 of 25 


The appearance of Ixempra on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Ixempra reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Ixempra Side Effects

    Did You Have a Ixempra Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Ixempra for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Ixempra Safety Alerts, Active Ingredients, Usage Information

    NDC0015-1910
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameIXEMPRA
    Nameixabepilone
    Dosage FormKIT
    Route
    On market since20071016
    LabelerE.R. Squibb & Sons, L.L.C.
    Active Ingredient(s)
    Strength(s)
    Unit(s)
    Pharma Class

    Ixempra Dosage, Warnings, Usage.

    Side Effects reported to FDA: 609

    Ixempra safety alerts: No

    Reported deaths: 96

    Reported hospitalizations: 193

    Latest Ixempra clinical trials

    Ixempra Reviews

    No reviews, be a first to report a side effect via side effect reporting form